Graduate School of Medical Sciences
A partnership with the Sloan Kettering Institute

News

This significant, foundational gift will launch the Ellen and Gary Davis Immune Monitoring Core, a critical research infrastructure that will serve as a repository for patient tumor samples, genomic sequencing and bioinformatics. The core will analyze and provide centralized, sensitive and quantitative patient data that investigators can use to advance their research into immunotherapy. This $2 million gift lays the cornerstone for further expansion in immunotherapy research and strengthens...

Read More

Yesterday we hosted our second-annual Three Minute Thesis® Competition. The event featured nine 3-minute presentations by Weill Cornell Graduate School and Gerstner Sloan Kettering Graduate School PhD students. The superb quality of the presentations reflects the high quality of research and outstanding communication skills of our students at both graduate schools.  The competition winners are listed below:

Judges’ Results

1st Prize
Mojdeh Shakiba (PBSB; PI: Andrea...

Read More

Two members of the WCM faculty have been elected to the prestigious American Academy of Arts and Sciences. Carl Nathan, MD, and David Hajjar,  PhD, are among the 213 scholars, scientists, and world leaders—including two others from Cornell University—who received the honor.

Carl Nathan, MD

Nathan, a prominent authority on tuberculosis, is the R.A. Rees Pritchett Professor of Microbiology and chairman of the Department of Microbiology and Immunology.

...

Read More

Chris Mason and a colleague swab New York City turnstiles for microbes.

The Bill & Melinda Gates Foundation has awarded a Grand Challenges Explorations Grant to a WCM project that will help researchers study antimicrobial resistance in fifty-four cities worldwide. The grant, which provides $100,000 in its first phase, will enable scientists to develop maps of the cities’ genetic differ- ences as well as their epigenetic states (which detail how genes are turned...

Read More

The addition of a chemical tag on an RNA molecule is the critical switch that inactivates one X chromosome in every cell, ensuring healthy development in all female mammals, according to new research by Weill Cornell Medicine investigators. The findings, reported Sept. 7 in Nature, could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.

Methyl marks on the RNA XIST enable it to trigger X chromosome...

Read More

This image shows human embryonic stem cell-derived pancreatic beta cell clusters after being transplanted into immunodeficient mice. Image credit: Drs. Hui Zeng and Min Guo

An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease. The research by Weill Cornell Medicine investigators was published Aug. 11 in Cell Stem Cell, and may extend the...

Read More

Dr. Jonathan Victor is part of a team of researchers that last fall received a $6.4 million grant from the National Science Foundation aimed at uncovering the universal algorithms at work in the nervous system when animals use olfaction to navigate. An understanding of this neural circuitry could shed light on the human brain — and spur the development of technology to replicate the services that animals provide, thus keeping highly trained and often valuable animals out of dangerous...

Read More

Saturday, October 8, 2016
10:00 AM – 2:00 PM
Belfer Research Building, Room 302 A-D
413 East 69th Street
New York, NY 10021

RSVP here

Read More

Asst. Dean Elizabeth Wilson-Anstey

The 6th annual SPARC Jr. conference took place on July 25 at Memorial Sloan Kettering Cancer Center’s Rockefeller Research Laboratories Auditorium. SPARC, which stands for Achieving Successful and Productive Academic Research Careers, was launched in 2010 in direct response to the National Institute of Health’s call for a vigilant and expedient response to the underrepresentation of women and racial/ethnic minority investigators in academic research.

...

Read More

Come meet aspiring entrepreneurs, inventors, scientists, clinicians, engineers and business professionals. Network with future teammates for our December Pitch Day!

Keynote Renier Brentjens, MD, PhD, Director, Cellular Therapeutics, MSKCC; Scientific Co-Founder of Juno Therapeutics (JUNO).

Featuring three BBI alumni startups:

Frank Borchetta, JD, Founder and CEO, Repairogen.

Kevin O'Rourke, MD, PhD candidate, Co-Founder, York Avenue Diagnostics.

Kate Rochlin,...

Read More

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-8906